147 related articles for article (PubMed ID: 1534701)
1. Mesangiocapillary glomerulonephritis.
D'Amico G; Ferrario F
J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S159-66. PubMed ID: 1534701
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
[TBL] [Abstract][Full Text] [Related]
3. [Mesangiocapillary glomerulonephritis].
Pál K; Nagy J
Orv Hetil; 1996 Jun; 137(26):1403-7. PubMed ID: 9182265
[TBL] [Abstract][Full Text] [Related]
4. Mesangiocapillary glomerulonephritis type III and idiopathic membranous glomerulopathy. Morphometric comparison of the deposits and glomerular basement membrane including clinico-morphological correlations.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1997; 48(1):43-8. PubMed ID: 9200960
[TBL] [Abstract][Full Text] [Related]
5. C3 nephritic factor and mesangiocapillary glomerulonephritis.
Williams DG
Pediatr Nephrol; 1997 Feb; 11(1):96-8. PubMed ID: 9035182
[TBL] [Abstract][Full Text] [Related]
6. [Clinico-morphologic correlations in various types of mesangiocapillary glomerulonephritis].
Severgina LO; Varshavskiĭ VA; Serov VV
Arkh Patol; 1993; 55(6):28-33. PubMed ID: 8122970
[TBL] [Abstract][Full Text] [Related]
7. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
[TBL] [Abstract][Full Text] [Related]
8. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
Okpechi IG; Dlamini TA; Duffield M; Rayner BL; Moturi G; Swanepoel CR
PLoS One; 2014; 9(11):e113302. PubMed ID: 25411791
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
Danilewicz M; Wagrowska-Danilewicz M
Nefrologia; 2001; 21(3):253-9. PubMed ID: 11471306
[TBL] [Abstract][Full Text] [Related]
11. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").
Colville D; Guymer R; Sinclair RA; Savige J
Am J Kidney Dis; 2003 Aug; 42(2):E2-5. PubMed ID: 12900843
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of clinical and morphologic changes in mesangiocapillary glomerulonephritis (MCGN) in reference to re-biopsy].
Wagrowska-Danilewicz M; Danilewicz M
Przegl Lek; 1994; 51(4):175-8. PubMed ID: 8058988
[TBL] [Abstract][Full Text] [Related]
13. Structural-functional relationships in type I mesangiocapillary glomerulonephritis.
Hattori M; Kim Y; Steffes MW; Mauer SM
Kidney Int; 1993 Feb; 43(2):381-6. PubMed ID: 8441233
[TBL] [Abstract][Full Text] [Related]
14. [A case of hypocomplementemic mesangial proliferative glomerulonephritis progressing to focal membranoproliferation without aggravation of urinalysis].
Okada S; Sasaki Y; Hayashi A; Fukazawa A; Nakagawa T; Utsunomiya Y; Kasagi T
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):469-74. PubMed ID: 10441999
[TBL] [Abstract][Full Text] [Related]
15. In situ complement activation in porcine membranoproliferative glomerulonephritis type II.
Jansen JH; Høgåsen K; Harboe M; Hovig T
Kidney Int; 1998 Feb; 53(2):331-49. PubMed ID: 9461093
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelial cells in the development of glomerular lesions of mesangiocapillary glomerulonephritis.
Onetti Muda A; Feriozzi S; Crescenzi A; Faraggiana T
J Pathol; 1995 Nov; 177(3):269-74. PubMed ID: 8551389
[TBL] [Abstract][Full Text] [Related]
17. Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.
Levy Y; George J; Yona E; Shoenfeld Y
Immunol Res; 1998 Aug; 18(1):55-60. PubMed ID: 9724849
[TBL] [Abstract][Full Text] [Related]
18. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the interstitial myofibroblasts in idiopathic mesangiocapillary glomerulonephritis type I.
Danilewicz M; Antoszczyk L; Wagrowska-Danilewicz M
Pathol Res Pract; 1999; 195(10):663-8. PubMed ID: 10549029
[TBL] [Abstract][Full Text] [Related]
20. Gaucher's disease and mesangiocapillary glomerulonephritis in childhood--a coincidence?
Halevi R; Davidovitz M; Mann S; Ben-Bassat M; Stark H; Eisenstein B
Pediatr Nephrol; 1993 Aug; 7(4):438-40. PubMed ID: 8398656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
